Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by Sheba Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00548457
First received: October 23, 2007
Last updated: January 28, 2008
Last verified: January 2008
  Purpose

The aim of this study is to show the frequency of endothelial dysfunction in patients suffering from ectatic coronary arteries as compared to those who have normal coronary arteries. Should this frequency be significant we would recommend initiating conventional treatment in those patients with ectatic coronary arteries as is the practice in patients with endothelial dysfunction without ectatic arteries


Condition
Coronary Artery Ectasia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Endothelial Function in Patients With Ectatic Compared to Normal Coronary Arteries

Further study details as provided by Sheba Medical Center:

Estimated Enrollment: 76
Study Start Date: May 2006

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients were recruited after passing cardiac catherization and diagnosed as having ectatic arteries.

Criteria

Inclusion Criteria:

  • Ectatic coronary arteries defined by cardiac catheterization
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00548457

Contacts
Contact: ARIK ASMAN, MD 972-3-5302454 asman@sheba.health.gov.il
Contact: Michael Shechter, MD 97235302617 shechter@sheba.health.gov.il

Locations
Israel
Heart Institute, Chaim Sheba Medical Center Recruiting
Tel Hashomer, Israel, 52621
Contact: Micahel Shechter, MD, MA    972-3-5302645    shechter@sheba.health.gov.il   
Principal Investigator: Arik Asman, MD         
Sub-Investigator: Pierre Chouraqui, MD         
Sub-Investigator: Michael Shechter, MD         
Sponsors and Collaborators
Sheba Medical Center
Investigators
Study Chair: Pierre Chouraqui, MD Sheba Medical Center
  More Information

No publications provided

Responsible Party: Dr. Pierre Chouraqui, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00548457     History of Changes
Other Study ID Numbers: SHEBA-06-4130-PC-CTIL
Study First Received: October 23, 2007
Last Updated: January 28, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:
the function of the endothelium of the arteries in patients suffering from ectatic coronary arteries

Additional relevant MeSH terms:
Dilatation, Pathologic
Pathological Conditions, Anatomical

ClinicalTrials.gov processed this record on July 20, 2014